Onset and Duration of Action of Ketotifen 0.025% and Emedastine 0.05% in Seasonal Allergic Conjunctivitis: Efficacy after Repeated Pollen Challenges in the Vienna Challenge Chamber

Author： Horak F.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.23, Iss.5, 2003-01, pp. : 329-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emedastine cost-effective therapy in allergic conjunctivitis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 311, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

A Method to Derive an Aggregated Score for Assessing Treatment Efficacy in Seasonal Allergic Conjunctivitis

By Le Pen C.  

Clinical Drug Investigation, Vol. 22, Iss. 11, 2002-01 ,pp. : 783-789

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Ketotifen Eye Drops as Adjunctive Therapy to Mometasone Nasal Spray in Subjects with Seasonal Allergic Rhinoconjunctivitis

By Horak F.  

Clinical Drug Investigation, Vol. 23, Iss. 9, 2003-01 ,pp. : 597-604

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries

By Pinto C.G.  

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 255-265

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Newer Antihistamines in the Treatment of Allergic Conjunctivitis

By Leonard Bielory   Kenneth W. Lien   Steve Bigelsen  

Drugs, Vol. 65, Iss. 2, 2005-01 ,pp. : 215-228

Adis International

Access to resources Recommend Favorite